Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
BeneHold dressing 15cm x 15cm square
20030400063
|
BeneHold dressing 15cm x 15cm square | Wound Management & Other Dressings | Dressings | No data available |
|
BeneHold dressing 20cm x 20cm square
20030400064
|
BeneHold dressing 20cm x 20cm square | Wound Management & Other Dressings | Dressings | No data available |
|
BeneHold dressing 5cm x 5cm square
20030400061
|
BeneHold dressing 5cm x 5cm square | Wound Management & Other Dressings | Dressings | No data available |
|
BeneHold TASA dressing 10cm x 10cm square
20030400086
|
BeneHold TASA dressing 10cm x 10cm square | Wound Management & Other Dressings | Dressings | No data available |
|
BeneHold TASA dressing 15cm x 15cm square
20030400087
|
BeneHold TASA dressing 15cm x 15cm square | Wound Management & Other Dressings | Dressings | No data available |
|
BeneHold TASA dressing 20cm x 20cm square
20030400088
|
BeneHold TASA dressing 20cm x 20cm square | Wound Management & Other Dressings | Dressings | No data available |
|
BeneHold TASA dressing 5cm x 5cm square
20030400085
|
BeneHold TASA dressing 5cm x 5cm square | Wound Management & Other Dressings | Dressings | No data available |
|
Benemid 500mg tablets (Imported)
1001040K0BFAAAA
|
Benemid (Imported) | Probenecid | Musculoskeletal and Joint Diseases | No data available |
|
Benemid 500mg tablets (Merck Sharp & Dohme Ltd)
1001040K0BBAAAA
|
Benemid (MSD) | Probenecid | Musculoskeletal and Joint Diseases | No data available |
|
Benepali 25mg/0.5ml inj pre-filled syringes
1001030D0BCACAD
|
Benepali | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Benerva 100mg tablets
0906026M0BBAKAG
|
Benerva | Thiamine hydrochloride | Nutrition and Blood | No data available |
|
Benerva 50mg tablets
0906026M0BBAJAF
|
Benerva | Thiamine hydrochloride | Nutrition and Blood | No data available |
|
Benlysta 120mg pdr for concentrate for inf vials
1001030Z0BBAAAA
|
Benlysta | Belimumab | Musculoskeletal and Joint Diseases | No data available |
|
Benlysta 400mg pdr for concentrate for inf vials
1001030Z0BBABAB
|
Benlysta | Belimumab | Musculoskeletal and Joint Diseases | No data available |
|
Benoral 2g granules sachets
1001010H0BBABAA
|
Benoral | Benorilate | Musculoskeletal and Joint Diseases | No data available |
|
Benoral 2g/5ml oral suspension
1001010H0BBACAD
|
Benoral | Benorilate | Musculoskeletal and Joint Diseases | No data available |
|
Benoral 750mg tablets
1001010H0BBAAAC
|
Benoral | Benorilate | Musculoskeletal and Joint Diseases | No data available |
|
Benorilate 2g granules sachets sugar free
1001010H0AAAAAA
|
Benorilate | Benorilate | Musculoskeletal and Joint Diseases | No data available |
|
Benorilate 2g/5ml oral suspension sugar free
1001010H0AAADAD
|
Benorilate | Benorilate | Musculoskeletal and Joint Diseases | No data available |
|
Benorilate 750mg tablets
1001010H0AAACAC
|
Benorilate | Benorilate | Musculoskeletal and Joint Diseases | No data available |
|
Benperidol 250micrograms/5ml oral suspension
0402010B0AAABAB
|
Benperidol | Benperidol | Central Nervous System | No data available |
|
Benperidol 500micrograms/5ml oral suspension
0402010B0AAACAC
|
Benperidol | Benperidol | Central Nervous System | No data available |
|
Benph 2mg tablets
0205040V0BCAAAB
|
Benph | Terazosin hydrochloride | Cardiovascular System | No data available |
|
Benph 5mg tablets
0205040V0BCABAC
|
Benph | Terazosin hydrochloride | Cardiovascular System | No data available |
|
Benquil 250microgram tablets
0402010B0BCAAAA
|
Benquil | Benperidol | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.